Literature DB >> 208962

A transitional cell carcinoma cell line.

G E Moore, R T Morgan, L A Quinn, L K Woods.   

Abstract

A transitional cell carcinoma cell line, COLO 232, was derived from a primary urinary bladder tumor in a Caucasian male. In culture, COLO 232 retained distinct uroepithelial phenotypic traits and produced both carcinoembryonic antigen and adrenocorticotropic hormone. COLO 232 had a chromosome mode of 58 and retained the X and Y chromosomes. Ten marker chromosomes were identified. COLO 232 will be of value for biochemical and immunological studies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208962     DOI: 10.1007/bf02616040

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  19 in total

1.  CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM.

Authors:  R G HAM
Journal:  Proc Natl Acad Sci U S A       Date:  1965-02       Impact factor: 11.205

2.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.

Authors:  B Drewinko; M M Romsdahl; L Y Yang; M J Ahearn; J M Trujillo
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

3.  High molecular weight forms of adrenocorticotropic hormone in the mouse pituitary and in a mouse pituitary tumor cell line.

Authors:  B A Eipper; R E Mains
Journal:  Biochemistry       Date:  1975-08-26       Impact factor: 3.162

4.  A cell line (SCABER) derived from squamous cell carcinoma of the human urinary bladder.

Authors:  C O'Toole; S Nayak; Z Price; W H Gilbert; J Waisman
Journal:  Int J Cancer       Date:  1976-06-15       Impact factor: 7.396

5.  Characterization of a cell line from human transitional cell cancer of the urinary tract.

Authors:  A Y Elliott; P Cleveland; J Cervenka; A E Castro; N Stein; T R Hakala; E E Fraley
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

6.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

7.  An analysis of the technical variables in the production of C bands.

Authors:  W H McKenzie; H A Lubs
Journal:  Chromosoma       Date:  1973       Impact factor: 4.316

8.  Lymphoid cell lines. Established from peripheral blood of persons with Down's syndrome.

Authors:  L K Woods; G E Moore; C J Bainbridge; C C Huang; C Huzella; L A Quinn
Journal:  N Y State J Med       Date:  1973-04-01

9.  Culture of normal human leukocytes.

Authors:  G E Moore; R E Gerner; H A Franklin
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

10.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

View more
  5 in total

1.  Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure.

Authors:  Shawn M Wnek; Taylor J Jensen; Paul L Severson; Bernard W Futscher; A Jay Gandolfi
Journal:  Toxicol Sci       Date:  2010-04-07       Impact factor: 4.849

2.  The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines.

Authors:  D H Vesole; G E Moore
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

3.  A human gallbladder adenocarcinoma cell line.

Authors:  R T Morgan; L K Woods; G E Moore; L McGavran; L A Quinn; T U Semple
Journal:  In Vitro       Date:  1981-06

4.  Establishment of cell strains from human urothelial carcinoma and their morphological characterization.

Authors:  T Kakuya; T Yamada; M Yokokawa; T Ueda
Journal:  In Vitro       Date:  1983-08

5.  Isolation and characterization of a novel human bladder cancer cell line: BK10.

Authors:  K M Roberson; D R Yancey; H Padilla-Nash; D W Edwards; W Nash; S Jacobs; G M Padilla; W A Larchian; C N Robertson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Jul-Aug       Impact factor: 2.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.